The purpose of the Responsibility in Drug Advertising Act of 2025 is to limit direct-to-consumer advertising for newly approved prescription drugs. The goal is to ensure that consumers receive accurate information about medications and to protect public health by preventing the promotion of drugs that may not yet have a proven safety record. Key provisions of the Act include a prohibition on direct-to-consumer advertising for a new drug during the first three years after its approval. This applies to all forms of advertising, including social media.